Lipella Pharmaceuticals Inc (NASDAQ: LIPO) is 41.64% higher on its value in year-to-date trading and has touched a low of $2.21 and a high of $12.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LIPO stock was last observed hovering at around $3.05 in the last trading session, with the day’s gains setting it 1.27%.
Currently trading at $4.32, the stock is 44.59% and 45.05% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 39.82 million and changing 41.64% at the moment leaves the stock 13.26% off its SMA200. LIPO registered -46.00% loss for a year compared to 6-month loss of 13.88%. The firm has a 50-day simple moving average (SMA 50) of $2.94796 and a 200-day simple moving average (SMA200) of $3.821275.
The stock witnessed a 48.97% gain in the last 1 month and extending the period to 3 months gives it a 72.52%, and is 69.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 32.07% over the week and 12.02% over the month.
Lipella Pharmaceuticals Inc (LIPO) has around 7 employees, a market worth around $5.23M and $0.48M in sales. Profit margin for the company is -881.73%. Distance from 52-week low is 95.48% and -64.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-292.24%).
The EPS is expected to shrink by -27.44% this year.
Lipella Pharmaceuticals Inc (LIPO) Top Institutional Holders
5.0 institutions hold shares in Lipella Pharmaceuticals Inc (LIPO), with institutional investors hold 1.24% of the company’s shares. The shares outstanding are 1.09M, and float is at 0.90M with Short Float at 2.51%. Institutions hold 0.88% of the Float.
Lipella Pharmaceuticals Inc (LIPO) Insider Activity
The most recent transaction is an insider purchase by Kaufman Jonathan H. SEC filings show that Kaufman Jonathan H bought 10,000 shares of the company’s common stock on May 14 ’24 at a price of $0.76 per share for a total of $7590.0. Following the purchase, the insider now owns 0.9 million shares.
Lipella Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 18 ’24 that Kaufman Jonathan H bought a total of 30,000 shares of the company’s common stock. The trade occurred on Mar 18 ’24 and was made at $0.79 per share for $23649.0. Following the transaction, the insider now directly holds 0.86 million shares of the LIPO stock.
Still, SEC filings show that on Mar 19 ’24, Kaufman Jonathan H acquired 25,000 shares at an average price of $0.87 for $21802.0. The insider now directly holds 888,849 shares of Lipella Pharmaceuticals Inc (LIPO).
